English
简体中文
Total: £ 56.28
Published Date: 2025-12-03 | Pages: 82 | Tables: 87 | Pharma & Healthcare
The global market for Radiological Marker was valued at US$ 4438 million in the year 2024 and is projected to reach a revised size of US$ 7270 million by 2031, growing at a CAGR of 7.4% during the forecast period.
Radiological Marker refers to a class of diagnostic products in which radioactive isotopes are used to label molecules, drugs, antibodies, or bioactive substances to enable precise visualization in medical imaging. By exploiting the biodistribution characteristics of radionuclides, these markers generate high-resolution images through PET and SPECT, allowing clinicians to detect metabolic changes, lesion distribution, and functional status. Radiological markers are widely applied in oncology, cardiovascular diseases, neurodegenerative conditions, inflammation, and metabolic disorders, forming a cornerstone of modern molecular imaging. With high sensitivity, high specificity, and functional imaging capability, they are indispensable tools in precision medicine, drug development, and early diagnostics, driving global healthcare toward earlier detection, higher accuracy, and personalized decision-making.The average gross profit margin of this product is 65%.
As global precision medicine advances, radiological markers are experiencing strong momentum due to their essential role in targeted imaging, functional diagnostics, and therapy monitoring. Growing investments in imaging infrastructure worldwide are increasing the need for highly specific and stable nuclear medicine markers in hospitals and research institutes. Meanwhile, pharmaceutical and biotech companies are expanding their use of radiological markers for drug imaging and companion diagnostics, making them critical evaluation tools in innovative drug development. Clearer regulatory frameworks for nuclear medicine technologies are also creating a more favorable environment for industry expansion.
Despite robust potential, the industry faces substantial challenges. R&D of radiological markers requires multidisciplinary capabilities across chemistry, nuclear medicine, and pharmaceutics, leading to high technical barriers and long validation cycles. Isotope supply chains are highly dependent on specialized production and regulatory systems, making them vulnerable to international capacity constraints and compliance risks. Regulatory differences across countries add further complexity to product approval and commercialization. As leading companies increase investments, competition is shifting toward technology-intensive differentiation, placing pressure on smaller players to balance innovation speed and cost efficiency.
Demand from hospitals, imaging centers, and research institutions is rapidly shifting from conventional general-purpose markers to high-specificity molecular imaging markers. As early cancer screening, therapeutic monitoring, and companion diagnostics gain traction, there is growing clinical need for radiological markers with higher resolution, lower dosage, and stronger binding capability. Pharmaceutical companies increasingly rely on radiological markers for evaluating drug distribution and pharmacokinetics, making them strategic assets for R&D collaboration. Additionally, the evolution of multi-modal imaging is broadening the application scope of radiological markers.
Core upstream materials include radioactive isotopes, chelating agents, and biomolecular carriers. Their purity, stability, and availability directly influence product quality and imaging performance. Due to the unique production requirements of isotopes, the upstream supply landscape remains limited and concentrated, pushing companies to focus on supply chain robustness and raw-material traceability. To meet the growing demand for high-performance markers, upstream suppliers are accelerating innovation in isotope purity, half-life control, and biocompatibility. Advancements at the raw-material level are becoming an important driver of overall industry value enhancement.
This report aims to provide a comprehensive presentation of the global market for Radiological Marker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiological Marker.
The Radiological Marker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiological Marker market comprehensively. Regional market sizes, concerning products by Type, by Application, by Imaging Modality and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiological Marker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cardinal Health
GE Healthcare
Lantheus Medical Imaging
Bracco Imaging
Curium Pharma
Jubilant Pharmova
Aurobindo Pharma
Siemens
NTP Radioisotopes
ANSTO
Polatom
China Isotope & Radiation
Yantai Dongcheng
Seed Medical
Segment by Type
Small-Molecule Contrast Agents
Radiotracers
Other
Segment by Imaging Modality
PET Radiotracers
SPECT Radiopharmaceuticals
Other
Segment by Administration
Intravenous (IV) Administration
Local Injection/Perfusion
Oral Contrast
Segment by Application
Hospital
Image Center
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Imaging Modality etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiological Marker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiological Marker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small-Molecule Contrast Agents
1.2.3 Radiotracers
1.2.4 Other
1.3 Market by Imaging Modality
1.3.1 Global Radiological Marker Market Size Growth Rate by Imaging Modality: 2020 VS 2024 VS 2031
1.3.2 PET Radiotracers
1.3.3 SPECT Radiopharmaceuticals
1.3.4 Other
1.4 Market by Administration
1.4.1 Global Radiological Marker Market Size Growth Rate by Administration: 2020 VS 2024 VS 2031
1.4.2 Intravenous (IV) Administration
1.4.3 Local Injection/Perfusion
1.4.4 Oral Contrast
1.5 Market by Application
1.5.1 Global Radiological Marker Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Hospital
1.5.3 Image Center
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Radiological Marker Market Perspective (2020-2031)
2.2 Global Radiological Marker Growth Trends by Region
2.2.1 Global Radiological Marker Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radiological Marker Historic Market Size by Region (2020-2025)
2.2.3 Radiological Marker Forecasted Market Size by Region (2026-2031)
2.3 Radiological Marker Market Dynamics
2.3.1 Radiological Marker Industry Trends
2.3.2 Radiological Marker Market Drivers
2.3.3 Radiological Marker Market Challenges
2.3.4 Radiological Marker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiological Marker Players by Revenue
3.1.1 Global Top Radiological Marker Players by Revenue (2020-2025)
3.1.2 Global Radiological Marker Revenue Market Share by Players (2020-2025)
3.2 Global Top Radiological Marker Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radiological Marker Revenue
3.4 Global Radiological Marker Market Concentration Ratio
3.4.1 Global Radiological Marker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiological Marker Revenue in 2024
3.5 Global Key Players of Radiological Marker Head office and Area Served
3.6 Global Key Players of Radiological Marker, Product and Application
3.7 Global Key Players of Radiological Marker, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiological Marker Breakdown Data by Type
4.1 Global Radiological Marker Historic Market Size by Type (2020-2025)
4.2 Global Radiological Marker Forecasted Market Size by Type (2026-2031)
5 Radiological Marker Breakdown Data by Application
5.1 Global Radiological Marker Historic Market Size by Application (2020-2025)
5.2 Global Radiological Marker Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radiological Marker Market Size (2020-2031)
6.2 North America Radiological Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radiological Marker Market Size by Country (2020-2025)
6.4 North America Radiological Marker Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiological Marker Market Size (2020-2031)
7.2 Europe Radiological Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radiological Marker Market Size by Country (2020-2025)
7.4 Europe Radiological Marker Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Radiological Marker Market Size (2020-2031)
8.2 Asia-Pacific Radiological Marker Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radiological Marker Market Size by Region (2020-2025)
8.4 Asia-Pacific Radiological Marker Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Radiological Marker Market Size (2020-2031)
9.2 Latin America Radiological Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radiological Marker Market Size by Country (2020-2025)
9.4 Latin America Radiological Marker Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiological Marker Market Size (2020-2031)
10.2 Middle East & Africa Radiological Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radiological Marker Market Size by Country (2020-2025)
10.4 Middle East & Africa Radiological Marker Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Details
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Radiological Marker Introduction
11.1.4 Cardinal Health Revenue in Radiological Marker Business (2020-2025)
11.1.5 Cardinal Health Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Radiological Marker Introduction
11.2.4 GE Healthcare Revenue in Radiological Marker Business (2020-2025)
11.2.5 GE Healthcare Recent Development
11.3 Lantheus Medical Imaging
11.3.1 Lantheus Medical Imaging Company Details
11.3.2 Lantheus Medical Imaging Business Overview
11.3.3 Lantheus Medical Imaging Radiological Marker Introduction
11.3.4 Lantheus Medical Imaging Revenue in Radiological Marker Business (2020-2025)
11.3.5 Lantheus Medical Imaging Recent Development
11.4 Bracco Imaging
11.4.1 Bracco Imaging Company Details
11.4.2 Bracco Imaging Business Overview
11.4.3 Bracco Imaging Radiological Marker Introduction
11.4.4 Bracco Imaging Revenue in Radiological Marker Business (2020-2025)
11.4.5 Bracco Imaging Recent Development
11.5 Curium Pharma
11.5.1 Curium Pharma Company Details
11.5.2 Curium Pharma Business Overview
11.5.3 Curium Pharma Radiological Marker Introduction
11.5.4 Curium Pharma Revenue in Radiological Marker Business (2020-2025)
11.5.5 Curium Pharma Recent Development
11.6 Jubilant Pharmova
11.6.1 Jubilant Pharmova Company Details
11.6.2 Jubilant Pharmova Business Overview
11.6.3 Jubilant Pharmova Radiological Marker Introduction
11.6.4 Jubilant Pharmova Revenue in Radiological Marker Business (2020-2025)
11.6.5 Jubilant Pharmova Recent Development
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Details
11.7.2 Aurobindo Pharma Business Overview
11.7.3 Aurobindo Pharma Radiological Marker Introduction
11.7.4 Aurobindo Pharma Revenue in Radiological Marker Business (2020-2025)
11.7.5 Aurobindo Pharma Recent Development
11.8 Siemens
11.8.1 Siemens Company Details
11.8.2 Siemens Business Overview
11.8.3 Siemens Radiological Marker Introduction
11.8.4 Siemens Revenue in Radiological Marker Business (2020-2025)
11.8.5 Siemens Recent Development
11.9 NTP Radioisotopes
11.9.1 NTP Radioisotopes Company Details
11.9.2 NTP Radioisotopes Business Overview
11.9.3 NTP Radioisotopes Radiological Marker Introduction
11.9.4 NTP Radioisotopes Revenue in Radiological Marker Business (2020-2025)
11.9.5 NTP Radioisotopes Recent Development
11.10 ANSTO
11.10.1 ANSTO Company Details
11.10.2 ANSTO Business Overview
11.10.3 ANSTO Radiological Marker Introduction
11.10.4 ANSTO Revenue in Radiological Marker Business (2020-2025)
11.10.5 ANSTO Recent Development
11.11 Polatom
11.11.1 Polatom Company Details
11.11.2 Polatom Business Overview
11.11.3 Polatom Radiological Marker Introduction
11.11.4 Polatom Revenue in Radiological Marker Business (2020-2025)
11.11.5 Polatom Recent Development
11.12 China Isotope & Radiation
11.12.1 China Isotope & Radiation Company Details
11.12.2 China Isotope & Radiation Business Overview
11.12.3 China Isotope & Radiation Radiological Marker Introduction
11.12.4 China Isotope & Radiation Revenue in Radiological Marker Business (2020-2025)
11.12.5 China Isotope & Radiation Recent Development
11.13 Yantai Dongcheng
11.13.1 Yantai Dongcheng Company Details
11.13.2 Yantai Dongcheng Business Overview
11.13.3 Yantai Dongcheng Radiological Marker Introduction
11.13.4 Yantai Dongcheng Revenue in Radiological Marker Business (2020-2025)
11.13.5 Yantai Dongcheng Recent Development
11.14 Seed Medical
11.14.1 Seed Medical Company Details
11.14.2 Seed Medical Business Overview
11.14.3 Seed Medical Radiological Marker Introduction
11.14.4 Seed Medical Revenue in Radiological Marker Business (2020-2025)
11.14.5 Seed Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Radiological Marker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small-Molecule Contrast Agents
Table 3. Key Players of Radiotracers
Table 4. Key Players of Other
Table 5. Global Radiological Marker Market Size Growth Rate by Imaging Modality (US$ Million): 2020 VS 2024 VS 2031
Table 6. Key Players of PET Radiotracers
Table 7. Key Players of SPECT Radiopharmaceuticals
Table 8. Key Players of Other
Table 9. Global Radiological Marker Market Size Growth Rate by Administration (US$ Million): 2020 VS 2024 VS 2031
Table 10. Key Players of Intravenous (IV) Administration
Table 11. Key Players of Local Injection/Perfusion
Table 12. Key Players of Oral Contrast
Table 13. Global Radiological Marker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 14. Global Radiological Marker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 15. Global Radiological Marker Market Size by Region (2020-2025) & (US$ Million)
Table 16. Global Radiological Marker Market Share by Region (2020-2025)
Table 17. Global Radiological Marker Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 18. Global Radiological Marker Market Share by Region (2026-2031)
Table 19. Radiological Marker Market Trends
Table 20. Radiological Marker Market Drivers
Table 21. Radiological Marker Market Challenges
Table 22. Radiological Marker Market Restraints
Table 23. Global Radiological Marker Revenue by Players (2020-2025) & (US$ Million)
Table 24. Global Radiological Marker Market Share by Players (2020-2025)
Table 25. Global Top Radiological Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiological Marker as of 2024)
Table 26. Ranking of Global Top Radiological Marker Companies by Revenue (US$ Million) in 2024
Table 27. Global 5 Largest Players Market Share by Radiological Marker Revenue (CR5 and HHI) & (2020-2025)
Table 28. Global Key Players of Radiological Marker, Headquarters and Area Served
Table 29. Global Key Players of Radiological Marker, Product and Application
Table 30. Global Key Players of Radiological Marker, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Radiological Marker Market Size by Type (2020-2025) & (US$ Million)
Table 33. Global Radiological Marker Revenue Market Share by Type (2020-2025)
Table 34. Global Radiological Marker Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 35. Global Radiological Marker Revenue Market Share by Type (2026-2031)
Table 36. Global Radiological Marker Market Size by Application (2020-2025) & (US$ Million)
Table 37. Global Radiological Marker Revenue Market Share by Application (2020-2025)
Table 38. Global Radiological Marker Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 39. Global Radiological Marker Revenue Market Share by Application (2026-2031)
Table 40. North America Radiological Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. North America Radiological Marker Market Size by Country (2020-2025) & (US$ Million)
Table 42. North America Radiological Marker Market Size by Country (2026-2031) & (US$ Million)
Table 43. Europe Radiological Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Europe Radiological Marker Market Size by Country (2020-2025) & (US$ Million)
Table 45. Europe Radiological Marker Market Size by Country (2026-2031) & (US$ Million)
Table 46. Asia-Pacific Radiological Marker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 47. Asia-Pacific Radiological Marker Market Size by Region (2020-2025) & (US$ Million)
Table 48. Asia-Pacific Radiological Marker Market Size by Region (2026-2031) & (US$ Million)
Table 49. Latin America Radiological Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 50. Latin America Radiological Marker Market Size by Country (2020-2025) & (US$ Million)
Table 51. Latin America Radiological Marker Market Size by Country (2026-2031) & (US$ Million)
Table 52. Middle East & Africa Radiological Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 53. Middle East & Africa Radiological Marker Market Size by Country (2020-2025) & (US$ Million)
Table 54. Middle East & Africa Radiological Marker Market Size by Country (2026-2031) & (US$ Million)
Table 55. Cardinal Health Company Details
Table 56. Cardinal Health Business Overview
Table 57. Cardinal Health Radiological Marker Product
Table 58. Cardinal Health Revenue in Radiological Marker Business (2020-2025) & (US$ Million)
Table 59. Cardinal Health Recent Development
Table 60. GE Healthcare Company Details
Table 61. GE Healthcare Business Overview
Table 62. GE Healthcare Radiological Marker Product
Table 63. GE Healthcare Revenue in Radiological Marker Business (2020-2025) & (US$ Million)
Table 64. GE Healthcare Recent Development
Table 65. Lantheus Medical Imaging Company Details
Table 66. Lantheus Medical Imaging Business Overview
Table 67. Lantheus Medical Imaging Radiological Marker Product
Table 68. Lantheus Medical Imaging Revenue in Radiological Marker Business (2020-2025) & (US$ Million)
Table 69. Lantheus Medical Imaging Recent Development
Table 70. Bracco Imaging Company Details
Table 71. Bracco Imaging Business Overview
Table 72. Bracco Imaging Radiological Marker Product
Table 73. Bracco Imaging Revenue in Radiological Marker Business (2020-2025) & (US$ Million)
Table 74. Bracco Imaging Recent Development
Table 75. Curium Pharma Company Details
Table 76. Curium Pharma Business Overview
Table 77. Curium Pharma Radiological Marker Product
Table 78. Curium Pharma Revenue in Radiological Marker Business (2020-2025) & (US$ Million)
Table 79. Curium Pharma Recent Development
Table 80. Jubilant Pharmova Company Details
Table 81. Jubilant Pharmova Business Overview
Table 82. Jubilant Pharmova Radiological Marker Product
Table 83. Jubilant Pharmova Revenue in Radiological Marker Business (2020-2025) & (US$ Million)
Table 84. Jubilant Pharmova Recent Development
Table 85. Aurobindo Pharma Company Details
Table 86. Aurobindo Pharma Business Overview
Table 87. Aurobindo Pharma Radiological Marker Product
Table 88. Aurobindo Pharma Revenue in Radiological Marker Business (2020-2025) & (US$ Million)
Table 89. Aurobindo Pharma Recent Development
Table 90. Siemens Company Details
Table 91. Siemens Business Overview
Table 92. Siemens Radiological Marker Product
Table 93. Siemens Revenue in Radiological Marker Business (2020-2025) & (US$ Million)
Table 94. Siemens Recent Development
Table 95. NTP Radioisotopes Company Details
Table 96. NTP Radioisotopes Business Overview
Table 97. NTP Radioisotopes Radiological Marker Product
Table 98. NTP Radioisotopes Revenue in Radiological Marker Business (2020-2025) & (US$ Million)
Table 99. NTP Radioisotopes Recent Development
Table 100. ANSTO Company Details
Table 101. ANSTO Business Overview
Table 102. ANSTO Radiological Marker Product
Table 103. ANSTO Revenue in Radiological Marker Business (2020-2025) & (US$ Million)
Table 104. ANSTO Recent Development
Table 105. Polatom Company Details
Table 106. Polatom Business Overview
Table 107. Polatom Radiological Marker Product
Table 108. Polatom Revenue in Radiological Marker Business (2020-2025) & (US$ Million)
Table 109. Polatom Recent Development
Table 110. China Isotope & Radiation Company Details
Table 111. China Isotope & Radiation Business Overview
Table 112. China Isotope & Radiation Radiological Marker Product
Table 113. China Isotope & Radiation Revenue in Radiological Marker Business (2020-2025) & (US$ Million)
Table 114. China Isotope & Radiation Recent Development
Table 115. Yantai Dongcheng Company Details
Table 116. Yantai Dongcheng Business Overview
Table 117. Yantai Dongcheng Radiological Marker Product
Table 118. Yantai Dongcheng Revenue in Radiological Marker Business (2020-2025) & (US$ Million)
Table 119. Yantai Dongcheng Recent Development
Table 120. Seed Medical Company Details
Table 121. Seed Medical Business Overview
Table 122. Seed Medical Radiological Marker Product
Table 123. Seed Medical Revenue in Radiological Marker Business (2020-2025) & (US$ Million)
Table 124. Seed Medical Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Authors List of This Report
List of Figures
Figure 1. Radiological Marker Picture
Figure 2. Global Radiological Marker Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radiological Marker Market Share by Type: 2024 VS 2031
Figure 4. Small-Molecule Contrast Agents Features
Figure 5. Radiotracers Features
Figure 6. Other Features
Figure 7. Global Radiological Marker Market Size Comparison by Imaging Modality (2020-2031) & (US$ Million)
Figure 8. PET Radiotracers Features
Figure 9. SPECT Radiopharmaceuticals Features
Figure 10. Other Features
Figure 11. Global Radiological Marker Market Size Comparison by Administration (2020-2031) & (US$ Million)
Figure 12. Intravenous (IV) Administration Features
Figure 13. Local Injection/Perfusion Features
Figure 14. Oral Contrast Features
Figure 15. Global Radiological Marker Market Size by Application (2020-2031) & (US$ Million)
Figure 16. Global Radiological Marker Market Share by Application: 2024 VS 2031
Figure 17. Hospital Case Studies
Figure 18. Image Center Case Studies
Figure 19. Other Case Studies
Figure 20. Radiological Marker Report Years Considered
Figure 21. Global Radiological Marker Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 22. Global Radiological Marker Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 23. Global Radiological Marker Market Share by Region: 2024 VS 2031
Figure 24. Global Radiological Marker Market Share by Players in 2024
Figure 25. Global Radiological Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. The Top 10 and 5 Players Market Share by Radiological Marker Revenue in 2024
Figure 27. North America Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. North America Radiological Marker Market Share by Country (2020-2031)
Figure 29. United States Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Canada Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Radiological Marker Market Share by Country (2020-2031)
Figure 33. Germany Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. France Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. U.K. Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Italy Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Russia Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Ireland Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Radiological Marker Market Share by Region (2020-2031)
Figure 41. China Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Japan Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. South Korea Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. India Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Australia & New Zealand Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Radiological Marker Market Share by Country (2020-2031)
Figure 49. Mexico Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Brazil Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Radiological Marker Market Share by Country (2020-2031)
Figure 53. Israel Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. UAE Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Cardinal Health Revenue Growth Rate in Radiological Marker Business (2020-2025)
Figure 57. GE Healthcare Revenue Growth Rate in Radiological Marker Business (2020-2025)
Figure 58. Lantheus Medical Imaging Revenue Growth Rate in Radiological Marker Business (2020-2025)
Figure 59. Bracco Imaging Revenue Growth Rate in Radiological Marker Business (2020-2025)
Figure 60. Curium Pharma Revenue Growth Rate in Radiological Marker Business (2020-2025)
Figure 61. Jubilant Pharmova Revenue Growth Rate in Radiological Marker Business (2020-2025)
Figure 62. Aurobindo Pharma Revenue Growth Rate in Radiological Marker Business (2020-2025)
Figure 63. Siemens Revenue Growth Rate in Radiological Marker Business (2020-2025)
Figure 64. NTP Radioisotopes Revenue Growth Rate in Radiological Marker Business (2020-2025)
Figure 65. ANSTO Revenue Growth Rate in Radiological Marker Business (2020-2025)
Figure 66. Polatom Revenue Growth Rate in Radiological Marker Business (2020-2025)
Figure 67. China Isotope & Radiation Revenue Growth Rate in Radiological Marker Business (2020-2025)
Figure 68. Yantai Dongcheng Revenue Growth Rate in Radiological Marker Business (2020-2025)
Figure 69. Seed Medical Revenue Growth Rate in Radiological Marker Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
